Related Experiment Video
Updated: Oct 13, 2026
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Restenosis after transluminal coronary angioplasty detected with exercise-gated radionuclide ventriculography
Insights
Exercise-gated radionuclide ventriculography effectively predicts coronary restenosis after angioplasty. Abnormal findings early post-procedure indicate higher restenosis rates, aiding in patient outcome prediction.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Transluminal coronary angioplasty (TCA) is a common procedure to treat coronary artery disease.
- Restenosis, the re-narrowing of the artery after TCA, remains a significant clinical challenge.
- Predictive tools are needed to identify patients at higher risk of restenosis post-TCA.
Purpose of the Study:
- To evaluate the utility of exercise-gated radionuclide ventriculography (EGRNV) in predicting coronary restenosis after successful TCA.
- To correlate EGRNV findings with the degree of angiographically confirmed restenosis at follow-up.
Main Methods:
- Forty-one patients underwent EGRNV before and after TCA, with follow-up assessments.
- Patients were categorized into three groups based on the degree of restenosis (≤20%, >20% to <50%, ≥50%).
- EGRNV parameters, including ejection fraction and wall motion, were analyzed and compared with restenosis severity.
Main Results:
- Abnormal EGRNV findings early after TCA were associated with a significantly higher degree of restenosis (41.2% vs. 19.0%, p<0.0001).
- EGRNV demonstrated 73% accuracy in predicting ≥50% restenosis immediately post-TCA and 77% at follow-up.
- Patients with significant restenosis (Group III) showed abnormal EGRNV findings more frequently (75% early, 88% late) compared to those with minimal restenosis (Group I) (5% early, 27% late).
Conclusions:
- Exercise-gated radionuclide ventriculography is a valuable tool for predicting coronary restenosis following transluminal coronary angioplasty.
- Early detection of abnormal cardiac function via EGRNV can identify patients likely to experience significant restenosis.
- EGRNV findings correlate well with the degree of restenosis, aiding in risk stratification and patient management.
Abstract:
Forty-one patients were evaluated with exercise-gated radionuclide ventriculography before and within 4 days after successful transluminal coronary angioplasty and 4 to 12 months later. Patients were subgrouped according to the degree of restenosis demonstrated angiographically at 4 to 12 months (Group I [n = 23]: less than or equal to 20%; Group II [n = 10]: greater than 20% but less than 50%; Group III [n = 8]: greater than or equal to 50%). Patients with abnormal findings on gated radionuclide ventriculography (less than 5 point increase in ejection fraction or wall motion deterioration) early after angioplasty were eventually found to have a greater degree of restenosis than were patients with normal findings (41.2 +/- 30.3 versus 19.0 +/- 25.4% restenosis, p less than 0.0001). The accuracy of abnormal radionuclide ventriculography in predicting 50% or greater restenosis was 73% immediately after angioplasty and 77% at the time of follow-up angiography. Gated radionuclide ventriculographic results were abnormal in 5% of Group I patients compared with 75% of Group III patients (p less than 0.01) early after angioplasty; at late follow-up, they were abnormal in 27% of Group I patients compared with 88% of Group III patients (p less than 0.01). Group I patients had a greater increase in ejection fraction than did Group III patients at early (+11.3 +/- 7.5 versus + 3.5 +/- 6.5 points, p less than 0.01) and late (+11.8 +/- 7.8 versus -1.9 +/- 8.7 points, p less than 0.0005) follow-up. It is concluded that gated radionuclide ventriculography is useful in predicting coronary restenosis after transluminal coronary angioplasty.
